SEP 08, 2016 1:30 PM PDT

The Paradigm Shift in Clinical Microbiology

Speaker
  • Scientific Affairs Manage, Roche
    Biography
      Steven is currently a Scientific Affairs Manager within the Medical and Scientific Affairs organization. He is responsible for interfacing with clinicians and key opinion leaders to assist in commercialization of products within the Roche Molecular Diagnostics portfolio. Steven has expertise in Donor Screening using both the cobas s201 platform as well as the cobas 6800 and 8800. He is also the lead for the Microbiology assays for Molecular MSA.

      Steven has worked at Roche for 5 years in several capacities. He worked directly with customers as part of Global Customer Support by handling complaints as well as assisting customers on site. He has also worked as part of the Operations Investigation Unit to perform quality investigations related to all kits and components manufactured at RMS. Steven has a bachelor's degree in Biotechnology from Rutgers University and a Ph.D. in Microbiology and Molecular Genetics from the University of Medicine and Dentistry of New Jersey.

      Steven currently lives with his wife, Marta, in Raritan, New Jersey.

    Abstract

    Multi-Drug Resistant Organisms (MDROs) are becoming a bigger and bigger concern throughout the world. Antibiotic resistance forms and spreads faster than pharmaceutical companies have been able to develop new antibiotic compounds. This stagnation in the development of new tools for the clinical laboratory to identify these organisms has equally been a problem. The traditional methods we use to identify and determine antibiotic resistance and susceptibility have not significantly changed for at least 50 years. Although these techniques are effective, they continue to require highly skilled staff, and multiple days to get a definitive result. Novel technologies, like Smarticles, are in development today with the goal to help identify drug resistant organisms the same day that samples are collected with automated systems. Technologies like Smarticles provide the promise of significantly improving our ability to identify carriers of these organisms and prevent them from spreading to other patients in the hospital.
    Dr. Cagas will give an overview of the growing threat that MDROs pose, how Clinical Microbiology has evolved to where it is today, and how novel technologies, like Smarticles, have the potential to cause a significant paradigm shift for clinical laboratories and the hospitals they serve.


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more